ArticleTranslational lung cancer research2026

Osalmid inhibits lung adenocarcinoma progression and enhances EGFR-TKI responses: a preclinical and translational study.

Leilei Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.